Behind the scenes of EQA–characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part IV – Benefits for participant laboratories
- 11 December 2024
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 63 (5) , 879-897
Abstract
The main stakeholders in external quality assessment (EQA) programs are the participants, in whose interests these challenges are ultimately organised. EQA schemes in the medical field contribute to improving the quality of patient care by evaluating the analytical and diagnostic quality of laboratory and point-of-care tests (POCT) by independent third parties and, if necessary, pointing out erroneous measurement results and analytical or diagnostic improvement potential. Other benefits include the option of using EQA samples for other important laboratory procedures, such as the verification or validation of in vitro diagnostic medical devices (IVD-MDs), a contribution to the estimation of measurement uncertainty, a means of training and educating laboratory staff through educational EQA programmes or samples, or even for independent and documented monitoring of staff competence, such as on samples with unusual or even exceptional characteristics. Participation in an EQA scheme for beneficiaries like medical, microbiological and histo- and molecular pathology laboratories, users of POCT and self-testing systems as well as National Metrology Institutes, calibration laboratories and reference laboratories that are dedicated to specific tasks and have particular expectations of the EQA scheme are presented here.Keywords
This publication has 64 references indexed in Scilit:
- A Comparison of Ukrainian Hospital Services and Functions Before and During the Russia-Ukraine WarJAMA Health Forum, 2024
- Detection of hepatitis C virus and parvovirus B19 in human plasma pools by nucleic-acid amplification techniques – Trends in results of EDQM proficiency testing studies from 2004 to 2018Biologicals, 2021
- Biomarker testing in oncology – Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSLVirchows Archiv, 2020
- Enhancing the accuracy of measurement of small molecule organic biomarkersAnalytical and Bioanalytical Chemistry, 2019
- Verifying and assigning own target values and ranges for internal quality controlAccreditation and Quality Assurance, 2019
- Laboratory Accuracy Improvement in the UK NEQAS Leucocyte Immunophenotyping Immune Monitoring Program: An Eleven‐Year Review via Longitudinal Mixed Effects ModelingCytometry Part B: Clinical Cytometry, 2017
- Verification of in vitro medical diagnostics (IVD) metrological traceability: Responsibilities and strategiesClinica Chimica Acta, 2014
- Retrospective analysis of 55,769 HbA1c EQA results obtained from professional laboratories and medical offices participating in surveys organized by two European EQA centers over a nine‐year periodJournal of Clinical Laboratory Analysis, 2011
- Flow cytometric CD34+ stem cell enumeration: Lessons from nine years' external quality assessment within the Benelux countriesCytometry Part B: Clinical Cytometry, 2007
- External Quality Control of Direct Antigen Tests to Detect Group A Streptococcal AntigenEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003